Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short-term stimulation with histone deacetylase inhibitor trichostatin a induces epithelial-mesenchymal transition in nasopharyngeal carcinoma cells without increasing cell invasion ability
Authors
Keywords
Nasopharyngeal carcinoma, Histone deacetylase inhibitor, Trichostatin a, ITSA-1, Epithelial mesenchymal transition, Proliferation, Migration
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-03-22
DOI
10.1186/s12885-019-5482-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy
- (2018) Dongfang Tang et al. Scientific Reports
- Hydrogen Sulfide Promotes Bone Homeostasis by Balancing Inflammatory Cytokine Signaling in CBS-Deficient Mice through an Epigenetic Mechanism
- (2018) Jyotirmaya Behera et al. Scientific Reports
- Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1-survivin downregulation at the late phase of treatment
- (2017) Shou-Chieh Wang et al. ONCOLOGY REPORTS
- Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases
- (2017) Xiaoyan Qiu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
- (2017) Peng Zhan et al. Recent Patents on Anti-Cancer Drug Discovery
- High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition
- (2017) Yanxia Wu et al. Scientific Reports
- Histone Modifications as Molecular Targets in Nasopharyngeal Cancer
- (2016) Sukanya Shyamasundar et al. CURRENT MEDICINAL CHEMISTRY
- Trichostatin A potentiates genistein-induced apoptosis and reverses EMT in HEp2 cells
- (2016) RUIXIA DU et al. Molecular Medicine Reports
- Inhibition of store-operated Ca2+ entry counteracts the apoptosis of nasopharyngeal carcinoma cells induced by sodium butyrate
- (2016) Wei Huang et al. Oncology Letters
- Trichostatin A, a histone deacetylase inhibitor, reverses epithelial–mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells
- (2015) Xiaoxiong Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Panobinostat for the Treatment of Multiple Myeloma
- (2015) J. P. Laubach et al. CLINICAL CANCER RESEARCH
- The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review
- (2015) F. Vahid et al. GENE
- A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
- (2015) B. J. Eigl et al. INVESTIGATIONAL NEW DRUGS
- Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
- (2015) Lee M Krug et al. LANCET ONCOLOGY
- HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells
- (2015) MEIYING JI et al. ONCOLOGY REPORTS
- Nasopharyngeal Carcinoma
- (2015) Sophia C. Kamran et al. Surgical Oncology Clinics of North America
- Interpreting the language of histone and DNA modifications
- (2014) Scott B. Rothbart et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
- (2014) Kwai Fung Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells
- (2014) RONG-FEI HAN et al. Molecular Medicine Reports
- Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition
- (2014) HANGUO JIANG et al. ONCOLOGY REPORTS
- Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts
- (2014) Mélanie Gressette et al. PLoS One
- Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro
- (2014) M. Saini et al. THERIOGENOLOGY
- Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2′-deoxycytidine on ovarian cancer
- (2013) F Meng et al. BRITISH JOURNAL OF CANCER
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epithelial-mesenchymal plasticity in carcinoma metastasis
- (2013) J. H. Tsai et al. GENES & DEVELOPMENT
- Trichostatin A, an HDAC Class I/II Inhibitor, Promotes Pi-Induced Vascular Calcification Via Up-Regulation of the Expression of Alkaline Phosphatase
- (2013) Takuya Azechi et al. Journal of Atherosclerosis and Thrombosis
- Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression
- (2013) Zhihua Shen et al. Journal of Translational Medicine
- Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein-Barr Virus
- (2013) K. F. Hui et al. MOLECULAR CANCER THERAPEUTICS
- Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor
- (2011) Yanis Boumber et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial-Mesenchymal Transition Predicts for Human Breast Cancer Recurrence
- (2011) D. D. Tran et al. MOLECULAR CANCER RESEARCH
- The prevalence and prevention of nasopharyngeal carcinoma in China
- (2011) Su-Mei Cao et al. Chinese Journal of Cancer
- A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma
- (2009) Monica Galli et al. ANNALS OF HEMATOLOGY
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
- (2008) T. H. Luu et al. CLINICAL CANCER RESEARCH
- Lack of Therapeutic Effect of the Histone Deacetylase Inhibitor Vorinostat in Patients with Metastatic Radioiodine-Refractory Thyroid Carcinoma
- (2008) Jennifer A. Woyach et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started